CA2571650A1 - Identification of makers in esophageal cancer, colon cancer, head and neck cancer and melanoma - Google Patents

Identification of makers in esophageal cancer, colon cancer, head and neck cancer and melanoma Download PDF

Info

Publication number
CA2571650A1
CA2571650A1 CA002571650A CA2571650A CA2571650A1 CA 2571650 A1 CA2571650 A1 CA 2571650A1 CA 002571650 A CA002571650 A CA 002571650A CA 2571650 A CA2571650 A CA 2571650A CA 2571650 A1 CA2571650 A1 CA 2571650A1
Authority
CA
Canada
Prior art keywords
mrna species
specific
lymph node
cells
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002571650A
Other languages
English (en)
French (fr)
Inventor
Tony E. Godfrey
Liqiang Xi
Siva Raja
Steven J. Hughes
William E. Gooding
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pittsburgh
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2571650A1 publication Critical patent/CA2571650A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002571650A 2004-07-09 2005-07-08 Identification of makers in esophageal cancer, colon cancer, head and neck cancer and melanoma Abandoned CA2571650A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US58701904P 2004-07-09 2004-07-09
US58659904P 2004-07-09 2004-07-09
US60/587,019 2004-07-09
US60/586,599 2004-07-09
PCT/US2005/024194 WO2006017151A2 (en) 2004-07-09 2005-07-08 Identification of makers in esophageal cancer, colon cancer, head and neck cancer and melanoma

Publications (1)

Publication Number Publication Date
CA2571650A1 true CA2571650A1 (en) 2006-02-16

Family

ID=35839738

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002571642A Abandoned CA2571642A1 (en) 2004-07-09 2005-07-08 Identification of markers in lung and breast cancer
CA002571650A Abandoned CA2571650A1 (en) 2004-07-09 2005-07-08 Identification of makers in esophageal cancer, colon cancer, head and neck cancer and melanoma

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA002571642A Abandoned CA2571642A1 (en) 2004-07-09 2005-07-08 Identification of markers in lung and breast cancer

Country Status (6)

Country Link
US (4) US20060068418A1 (enExample)
EP (6) EP1774025A4 (enExample)
JP (3) JP2008505644A (enExample)
AU (2) AU2005271960B2 (enExample)
CA (2) CA2571642A1 (enExample)
WO (2) WO2006017150A2 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060003391A1 (en) * 2003-08-11 2006-01-05 Ring Brian Z Reagents and methods for use in cancer diagnosis, classification and therapy
US20050112622A1 (en) 2003-08-11 2005-05-26 Ring Brian Z. Reagents and methods for use in cancer diagnosis, classification and therapy
EP1774025A4 (en) * 2004-07-09 2009-09-16 Univ Pittsburgh IDENTIFYING MARKERS IN LUNG AND BREAST CANCER
US20080131916A1 (en) * 2004-08-10 2008-06-05 Ring Brian Z Reagents and Methods For Use In Cancer Diagnosis, Classification and Therapy
CN101068937A (zh) * 2004-09-20 2007-11-07 匹兹堡大学 多重模式复合反应测序方法
JP4968577B2 (ja) * 2006-04-11 2012-07-04 エフ．ホフマン−ラ ロシュ アーゲー サイトケラチン１９（ＣＫ１９）ｍＲＮＡの迅速測定法、並びにそのためのプライマー及びプローブ
US8119352B2 (en) * 2006-06-20 2012-02-21 Cepheld Multi-stage amplification reactions by control of sequence replication times
JP4943074B2 (ja) * 2006-07-03 2012-05-30 シスメックス株式会社 がん転移の判定方法及び装置
US7622456B2 (en) * 2006-11-06 2009-11-24 Non-Profit Organization Chang Gung Memorial Hospital Method on clinical applications in head neck cancer by using DSG3 molecule for predicting malignant degree of cancer, serving as a molecular target and using RNA jamming sequence on inhibition-specific of DSG3 expression
AU2007322206A1 (en) * 2006-11-13 2008-05-29 Source Precision Medicine, Inc. Gene expression profiling for identification, monitoring, and treatment of lung cancer
WO2010144808A2 (en) 2009-06-12 2010-12-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Identification of dsg-3 as a biomarker for the detection of metastasis in lymph nodes
CN106367478A (zh) 2009-12-22 2017-02-01 雅芳产品公司 桩蛋白刺激组合物及其化妆品用途
EP2514835B1 (en) * 2009-12-24 2013-07-17 National University Corporation Ehime University Method for analyzing cervical lymph node metastasis, and tumor marker for head and neck cancer
US20120171133A1 (en) 2010-12-30 2012-07-05 Avon Products, Inc. Modulation of Dynein in Skin
JP6154809B2 (ja) 2011-06-27 2017-06-28 エーザイ・アール・アンド・ディー・マネジメント株式会社 アルツハイマー病を示すマイクロｒｎａバイオマーカー
US10195136B2 (en) 2011-08-24 2019-02-05 Avon Products, Inc. Collagen and elastin stimulating compositions and uses thereof
US8632827B2 (en) 2011-12-13 2014-01-21 Avon Products, Inc Modulation of thymosin beta-4 in skin
MX349544B (es) 2011-12-13 2017-08-02 Avon Prod Inc Extractos de maesa japonica y métodos de uso.
JP2013208420A (ja) * 2012-03-02 2013-10-10 Nippon Koden Corp 心電図解析レポート、心電図解析装置及び心電図解析プログラム
JP6419694B2 (ja) * 2012-06-29 2018-11-07 デピュイ・シンセス・プロダクツ・インコーポレイテッド 横方向挿入脊椎インプラント
CN108949992B (zh) * 2018-08-14 2021-11-05 高鑫 一种与食管鳞癌及其分级相关的生物标志物
CN109913552B (zh) * 2019-03-27 2020-08-04 河北医科大学第四医院 一种食管鳞癌诊疗靶点及应用
EP4116435A1 (en) * 2021-07-08 2023-01-11 Universidad de Granada In vitro method for the diagnosis and/or prognosis of malignant melanoma
WO2023081988A1 (pt) * 2021-11-09 2023-05-19 Coelho Guilherme Portela Método para predição de eficácia de tratamento para câncer de mama

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5274087A (en) * 1986-08-13 1993-12-28 Molecular Diagnostics, Inc. cDNA coding for carcinoembryonic antigen (CEA)
US6416952B1 (en) 1989-06-07 2002-07-09 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US6406844B1 (en) 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
DE69213112T2 (de) 1991-06-20 1997-04-03 Hoffmann La Roche Verbesserte Methoden zur Nukleinsäure-Amplifizierung
US6309823B1 (en) * 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
PT732929E (pt) 1993-10-29 2008-08-26 Brigham & Womens Hospital Utilização terapêutica de ''engodos'' de elementos cis in vivo
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
ATE397097T1 (de) * 1995-03-17 2008-06-15 Wayne John Cancer Inst Nachweis von brustmetastasen unter verwendung eines mehrfachmarker-tests
WO1996039535A1 (en) 1995-06-06 1996-12-12 Jan Vijg Method of and apparatus for diagnostic dna testing
US5882856A (en) * 1995-06-07 1999-03-16 Genzyme Corporation Universal primer sequence for multiplex DNA amplification
US6031129A (en) * 1995-10-03 2000-02-29 Quantum Chemical Corporation Use of pentavalent group VA oxides in acetic acid processing
US5854033A (en) 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
US5837442A (en) * 1995-11-29 1998-11-17 Roche Molecular Systems, Inc. Oligonucleotide primers for amplifying HCV nucleic acid
AUPO188396A0 (en) 1996-08-26 1996-09-19 Insearch Limited Detection of protozoan parasites
US5958349A (en) * 1997-02-28 1999-09-28 Cepheid Reaction vessel for heat-exchanging chemical processes
US5843721A (en) 1997-07-03 1998-12-01 Tularik Inc. Nucleic acids encoding human NIK protein
GB9719044D0 (en) 1997-09-08 1997-11-12 Inst Of Ophthalmology Assay
AU758407B2 (en) 1997-12-24 2003-03-20 Cepheid Integrated fluid manipulation cartridge
US6660228B1 (en) 1998-03-02 2003-12-09 Cepheid Apparatus for performing heat-exchanging, chemical reactions
US6037129A (en) * 1998-05-28 2000-03-14 Medical University Of South Carolina Multi-marker RT-PCR panel for detecting metastatic breast cancer
US6306643B1 (en) 1998-08-24 2001-10-23 Affymetrix, Inc. Methods of using an array of pooled probes in genetic analysis
US6245517B1 (en) 1998-09-29 2001-06-12 The United States Of America As Represented By The Department Of Health And Human Services Ratio-based decisions and the quantitative analysis of cDNA micro-array images
US6431476B1 (en) 1999-12-21 2002-08-13 Cepheid Apparatus and method for rapid ultrasonic disruption of cells or viruses
CA2361621A1 (en) 1999-01-27 2000-08-03 Richard Jove Inhibition of stat3 signal transduction for human cancer therapy
US6251601B1 (en) 1999-02-02 2001-06-26 Vysis, Inc. Simultaneous measurement of gene expression and genomic abnormalities using nucleic acid microarrays
US6300069B1 (en) 1999-05-03 2001-10-09 Qiagen Gmbh Generation and amplification of nucleic acids from ribonucleic acids
JP4078073B2 (ja) 1999-05-28 2008-04-23 シーフィード 流体試料分析装置および方法
WO2000072970A1 (en) 1999-05-28 2000-12-07 Cepheid Cartridge for conducting a chemical reaction
SE9902410D0 (sv) 1999-06-24 1999-06-24 Cavidi Tech Ab Reverse transcriptase assay kit, use thereof and method for analysis of RT activity in biological samples
AU5830400A (en) * 1999-06-30 2001-01-22 Arto Orpana Diagnostic method for squamous cell carcinoma
US6403037B1 (en) 2000-02-04 2002-06-11 Cepheid Reaction vessel and temperature control system
EP1272665B1 (en) * 2000-03-27 2010-05-26 Thomas Jefferson University Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
US6783934B1 (en) 2000-05-01 2004-08-31 Cepheid, Inc. Methods for quantitative analysis of nucleic acid amplification reaction
AU2001280987A1 (en) * 2000-08-03 2002-02-18 Corixa Corporation Compositions and methods for the therapy and diagnosis of head and neck cancer
US6374684B1 (en) 2000-08-25 2002-04-23 Cepheid Fluid control and processing system
US8048386B2 (en) 2002-02-25 2011-11-01 Cepheid Fluid processing and control
AU2002216009A1 (en) * 2000-11-03 2002-05-15 Michael Giesing Clinical and functional validation of targets from disseminated cancer cells
US6312929B1 (en) 2000-12-22 2001-11-06 Cepheid Compositions and methods enabling a totally internally controlled amplification reaction
AU2002247248B2 (en) * 2001-03-02 2007-07-05 University Of Pittsburgh Of The Commonwealth System Of Higher Education PCR method
EP1464695A1 (en) 2001-12-26 2004-10-06 Olympus Corporation Reaction vessel and reaction vessel holding mechanism
US6819027B2 (en) 2002-03-04 2004-11-16 Cepheid Method and apparatus for controlling ultrasonic transducer
ATE529535T1 (de) * 2002-03-13 2011-11-15 Genomic Health Inc Genexpressionsprofilierung in einer biopsie unterzogenem tumorgewebe
WO2003087766A2 (en) * 2002-04-05 2003-10-23 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets
WO2004024957A2 (en) * 2002-09-12 2004-03-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method for detection of micro-metastasis
ATE522620T1 (de) * 2002-11-14 2011-09-15 Wayne John Cancer Inst Nachweis von micrometastasierung von melanomen und brustkrebs an in paraffin eingegbetteten, von tumoren abführenden lymphknoten mittels quantitativer multimaker rt-pcr
US20040101859A1 (en) 2002-11-25 2004-05-27 Cepheid Compositions, methods and kits for polynucleotide amplification reactions and microfluidic devices
WO2005055804A2 (en) * 2003-12-02 2005-06-23 Musc Foundation For Research Development Methods and compositions for diagnosing epithelial cell cancer
EP1774025A4 (en) * 2004-07-09 2009-09-16 Univ Pittsburgh IDENTIFYING MARKERS IN LUNG AND BREAST CANCER
CN101068937A (zh) * 2004-09-20 2007-11-07 匹兹堡大学 多重模式复合反应测序方法
US9032602B2 (en) 2011-07-15 2015-05-19 The Boeing Company Methods and systems for in-process quality control during drill-fill assembly

Also Published As

Publication number Publication date
US20100240037A1 (en) 2010-09-23
EP2275578A2 (en) 2011-01-19
US20110312515A1 (en) 2011-12-22
EP2275578A3 (en) 2011-11-30
AU2005271961B8 (en) 2011-11-24
EP2287329A2 (en) 2011-02-23
US7662561B2 (en) 2010-02-16
US20060068418A1 (en) 2006-03-30
EP2468889A2 (en) 2012-06-27
JP2008510454A (ja) 2008-04-10
EP1774030A2 (en) 2007-04-18
JP2008505644A (ja) 2008-02-28
EP2287329A3 (en) 2011-08-03
AU2005271961B2 (en) 2011-10-13
EP2272987A3 (en) 2012-04-11
CA2571642A1 (en) 2006-02-16
EP2468889A3 (en) 2012-07-11
EP1774030A4 (en) 2008-07-09
EP1774025A2 (en) 2007-04-18
JP2012005500A (ja) 2012-01-12
AU2005271960A1 (en) 2006-02-16
WO2006017151A2 (en) 2006-02-16
WO2006017151A3 (en) 2007-01-11
US20060019290A1 (en) 2006-01-26
EP1774025A4 (en) 2009-09-16
EP2272987A2 (en) 2011-01-12
AU2005271960B2 (en) 2011-12-08
WO2006017150A2 (en) 2006-02-16
AU2005271961A1 (en) 2006-02-16
WO2006017150A3 (en) 2009-04-09

Similar Documents

Publication Publication Date Title
US20100240037A1 (en) Identification of markers in esophageal cancer, colon cancer, head and neck cancer, and melanoma
US20090226881A1 (en) Multiple mode multiplex reaction quenching method
EP1272668B1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
WO2002070751A1 (en) Pcr method
AU2002247248A1 (en) PCR method
CA3026809A1 (en) Compositions and methods for diagnosing lung cancers using gene expression profiles
AU2005250479B2 (en) Diagnosing or predicting the course of breast cancer
AU2011253566A1 (en) Identification of markers in esophageal cancer, colon cancer, head and neck cancer and melanoma
EP1865076A1 (en) Detection of lymph node metastasis from gastric carcinoma
CA2709106C (en) Methods and reagents for the early detection of melanoma

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130709